Cesar Camacho-Lopez

Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination.

Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination.

Journal: NPJ vaccines

Published: January 14, 2026

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 25, 2025

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 25, 2025

Rabies glycoprotein engineering for improved stability and expression.

Rabies glycoprotein engineering for improved stability and expression.

Journal: Vaccine

Published: April 28, 2025

Editorial: RNA vaccines for prevalent and newly emerging diseases.

Editorial: RNA vaccines for prevalent and newly emerging diseases.

Journal: Frontiers in immunology

Published: August 01, 2024

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.

Journal: Frontiers in immunology

Published: February 26, 2024

Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors.

Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors.

Journal: NPJ vaccines

Published: February 23, 2024

Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective.

Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective.

Journal: Frontiers in immunology

Published: February 09, 2024

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus.

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus.

Journal: International journal of molecular sciences

Published: March 14, 2022

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.

Journal: JCI insight

Published: November 09, 2021

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

Journal: Cell

Published: May 25, 2021

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.

Journal: Scientific reports

Published: March 26, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026